Pfizer Inc. recalls Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (3
Recalled July 1, 2020 · FDA recall D-1342-2020 · Pfizer
Hazard
Failed Dissolution Specifications · FDA Class III
Units
544400 packages
Sold at
Nationwide within the United States
Description
Failed Dissolution Specifications
Product
Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →